OTC Markets EXMKT - Delayed Quote USD

Verde Science, Inc. (VRCI)

Compare
0.0000
0.0000
(0.00%)
At close: February 14 at 3:00:00 PM EST
Loading Chart for VRCI
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0000
  • Volume 564,634
  • Avg. Volume 0
  • Market Cap (intraday) 45,349
  • Beta (5Y Monthly) -5.12
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Verde Science, Inc., a pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions. The company was formerly known as Rango Energy, Inc. and changed its name to Verde Science, Inc. in May 2014. Verde Science, Inc. was founded in 2007 and is based in Dallas, Texas.

www.verdescienceinc.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VRCI

View More

Performance Overview: VRCI

Trailing total returns as of 2/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

VRCI
0.00%
S&P 500
3.96%

1-Year Return

VRCI
0.00%
S&P 500
22.28%

3-Year Return

VRCI
0.00%
S&P 500
38.92%

5-Year Return

VRCI
98.33%
S&P 500
80.90%

Compare To: VRCI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VRCI

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -5,291.10%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -605.56k

  • Diluted EPS (ttm)

    0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    812

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    421.84k

Research Analysis: VRCI

View More

Company Insights: VRCI

Research Reports: VRCI

View More

People Also Watch